Jacobson Pharma Corp. Ltd. | Mutual Funds
Mutual Funds that own Jacobson Pharma Corp. Ltd.
Grandeur Peak Emerging Markets Opportunities Fund
5,020,000
0.25%
0
0.28%
04/30/2018
Grandeur Peak Global Reach Fund
3,295,000
0.16%
-270,000
0.21%
04/30/2018
Baring Investment Funds Plc - China Select Fund
1,985,000
0.1%
0
1.07%
10/31/2017
Nomura Asset Chinese Equity (Ex-A Share) Mother Fund
1,881,758
0.09%
1,881,758
1.12%
10/25/2016
Pioneer Funds - China Equity
1,572,000
0.08%
-748,000
0.12%
01/31/2018
Matthews China Small Companies Fund
1,220,000
0.06%
0
0.68%
03/29/2018
Ferique Asian
880,000
0.04%
0
0.2%
12/31/2017
775,000
0.04%
200,000
0.45%
04/30/2018
492,000
0.02%
492,000
0.91%
04/30/2018
Nomura Asset Asia Open Fund
262,977
0.01%
-693,642
0.14%
10/26/2017
Address |
Unit 2313-18, 23/F Hong Kong Hong Kong
|
Employees
|
- |
Website |
http://www.jacobsonpharma.com |
Updated |
07/08/2019 |
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. It operates through the following segments: Generic Drugs, Proprietary Medicines, and Wholesale and Retal. The Generic Drugs segment develops, manufactures and distributes a host of off-patent medicines for various therapeutic use. |